Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Epidemiology of gout: An update

(2011) E.U.R. Smith et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Gout therapeutics: new drugs for an old disease

(2010) Christopher M Burns et al.   LANCET

Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study

(2008) Adriana G. Ioachimescu et al.   ARTHRITIS AND RHEUMATISM

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial

(2008) H. RALPH Schumacher et al.   ARTHRITIS AND RHEUMATISM

Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study

(2008) Alexander M. Strasak et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Uric Acid and Cardiovascular Risk

(2008) Daniel I. Feig et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men

(2007) A. Strasak et al.   CLINICAL CHEMISTRY